Mazdutide Peptide

Its interest as a research tool comes from that natural template. Where survodutide and retatrutide are engineered scaffolds, mazdutide follows the receptor balance nature already built into oxyntomodulin, which makes it useful for asking whether an oxyntomodulin-like ratio behaves differently from a designed one. Investigators use it in cyclic-AMP potency panels, hepatocyte and adipocyte assays, and rodent energy-balance work where glucagon-driven expenditure and GLP-1-driven intake reduction are measured together.

Oxyntomodulin, the template, is a 37-residue proglucagon product: the full glucagon sequence extended at the C-terminus by an eight-residue basic tail. It activates both the glucagon and the GLP-1 receptors natively but is cleared within minutes, and mazdutide is the stabilised version of that arrangement, with protease-resistant substitutions and a lipid side chain for reversible albumin binding, catalogued under CAS 2259884-42-1 and appearing in the literature as IBI362 and LY3305677. Searching all three identifiers is worth doing when assembling references, since the development codes dominate the earlier papers. Vials are offered at 5 mg, 10 mg and 20 mg, reconstituted in bacteriostatic water or in dilute alkaline or phosphate buffers, with the lyophilized cake at −20 °C and solutions at 2–8 °C.

Mazdutide ships as a lyophilized powder, so nothing on this page can state a concentration: the figure you work with is the one you create when you add diluent. Put the vial mass and the volume you intend to use into the peptide reconstitution calculator and it returns mg/mL, mcg/mL and the mass sitting at each mark on a U-100 syringe.